Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|11|1002-1010

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.11, 2014-10, pp. : 1002-1010

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-05 ,pp. : 1107-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Current Biological Therapies for Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4127-4147

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapies based on enhancement of gut innate immunity in inflammatory bowel disease

By Fiasse René   Dewit Olivier  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1423-1441

Informa Healthcare

Access to resources Recommend Favorite

Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 3, 2018-01 ,pp. : 234-243

Bentham Science Publishers

Access to resources Recommend Favorite